- Advanced Ovarian Carcinoma Consolidation Treatment - Yes or No?2003 | First Faculty of Medicine
- The efficacy of rituximab in consolidation treatment after chemotherapy CHOP in patients with follicular lymphoma2005 | First Faculty of Medicine
- Advanced Ovarian Carcinoma Consolidation Treatment - Yes or No?2003 | Faculty of Medicine in Hradec Králové
- The efficacy of rituximab in consolidation treatment after chemotherapy CHOP in patients with follicular lymphoma +12005 | Faculty of Medicine in Hradec Králové
- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Faculty of Medicine in Pilsen
- WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia2020 | First Faculty of Medicine
- Midostaurin, current overview and clinical experience of IHBT in 2021 - case reports2021 | First Faculty of Medicine
- The role of durvalumab in the treatment of stage III NSCLC2020 | First Faculty of Medicine
- Modern concepts in the treatment of chronic lymphocytic leukemia +12009 | Faculty of Medicine in Hradec Králové
- Modern concepts in the treatment of chronic lymphocytic leukemia2009 | First Faculty of Medicine
- Pembrolitzumab in the treatment of NSCLC2017 | Publication without faculty affiliation
- Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML - Results from Study AML-BFM 20042015 | Second Faculty of Medicine
- Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment2015 | Second Faculty of Medicine
- Treatment of Refractory Systemic Hodgkin Lymphoma and Secondary CNS Involvement with Brentuximab Vedoti2021 | Third Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | Second Faculty of Medicine, First Faculty of Medicine
- Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group2016 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Advances in management of stage III non-small cell lung cancer2022 | First Faculty of Medicine
- Immunotherapy - Perspectives of Application in the Therapy of Ovarian Carcinomas2004 | Second Faculty of Medicine
- Radiotherapy of lung cancer alone and with relation to chemotherapy2019 | First Faculty of Medicine
- Radiotherapy of lung cancer2019 | First Faculty of Medicine
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine
- Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol2021 | Second Faculty of Medicine